fbpx
September 30, 2021

CVST After COVID-19 Vaccine: New Data Confirm High Mortality Rate CVST After COVID-19 Vaccine: New Data Confirm High Mortality Rate

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A new series of cases of cerebral venous sinus thrombosis (CVST) linked […]
September 29, 2021

FDA Okays New Oral CGRP Antagonist for Migraine Prevention FDA Okays New Oral CGRP Antagonist for Migraine Prevention

The US Food and Drug Administration has approved atogepant (Qulipta), a novel calcitonin gene-related peptide (CGRP) receptor antagonist, for the prevention of episodic migraine, the manufacturer […]
September 28, 2021

Optogenetics Scientists Take Lasker Prize for Basic Research Optogenetics Scientists Take Lasker Prize for Basic Research

Three researchers who have been integral to the discovery and development of using light-sensitive proteins to determine the function of neurons ­— and possibly control them […]
September 27, 2021

Novel Drug Effective for Tremor, but With Significant Side Effects Novel Drug Effective for Tremor, but With Significant Side Effects

The investigational oral, neuroactive, steroid-positive allosteric modulator SAGE-324/BIIB124 (SAGE-324) is effective for treating essential tremor ― but problems with tolerability may limit its usefulness, new research […]
September 24, 2021

Apple Devices Identify Early Parkinson’s Disease Apple Devices Identify Early Parkinson’s Disease

Apple Watches and iPhones can differentiate between individuals with early, untreated Parkinson’s disease (PD) and healthy controls, new research shows. Results from the WATCH-PD study show […]
September 24, 2021

Pandemic-Related Stressors Identified in Parkinson’s Disease Pandemic-Related Stressors Identified in Parkinson’s Disease

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Social distancing and the shutdown of services like physical and occupational therapy […]
September 23, 2021

Experimental Botulinum Toxin More Effective in Cervical Dystonia? Experimental Botulinum Toxin More Effective in Cervical Dystonia?

An investigative formulation of a botulinum neurotoxin (BoNT) for cervical dystonia may significantly reduce the risk of dysphagia after injection compared with existing injections, and may […]
September 23, 2021

Synthetic Triglyceride Shows Potential in Huntington Disease Synthetic Triglyceride Shows Potential in Huntington Disease

The synthetic medium-chain triglyceride triheptanoin has shown potential to restore brain energy and decrease caudate atrophy in Huntington disease, and improved motor function for up to […]
September 23, 2021

COVID-19 a Rare Trigger for Guillain-Barré Syndrome COVID-19 a Rare Trigger for Guillain-Barré Syndrome

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Although Guillain-Barré syndrome (GBS) may rarely follow a recent infection with SARS-CoV-2, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0